Knee arthrosis: First US Patients Receive AGILI-C (Israel) Implants

CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, and two LSU Health New Orleans orthopaedic surgeons announced today...

Read more

CartiHeal (Israel) Announces FDA IDE Approval of its Agili-C Implant for the Treatment of Joint Surface Lesions

Israeli company CartiHeal (2009), developer of a cell-free, off-the-shelf implant for use in cartilage and osteochondral defects, announced today the FDA approval of the...

Read more

Israël Science Info